NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Seritage Growth Properties (“Seritage” or the “Company”) (NYSE: SRG). Such investors are advised to contact Danielle Peyton at [email protected] […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Maxeon Solar Technologies, Ltd. (“Maxeon” or the “Company”) (NASDAQ: MAXN). Such investors are advised to contact Danielle Peyton at […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The […]
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STMicroelectronics N.V. (“ST” or the “Company”) (NYSE: STM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]
